For GLP1-RA there was moderate certainty that markers of reduced insulin secretion, either directly measured (e.g. c-peptide or HOMA-B) or proxy measures, such as diabetes duration, were associated with reduced glycaemic response to GLP1-RA, although the majority of evidence was from observational studies. This evidence concerns the gene INS and diabetes mellitus.